JAZZ

Jazz Pharmaceuticals Announces Management Change

[PR Newswire] – DUBLIN, Feb. 25, 2014 /PRNewswire/ — Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that Kathryn Falberg, executive vice president and chief financial officer (CFO), has resigned from the company, … moreView todays social media effects on JAZZView the latest stocks trending across Twitter. Click to view dashboardSee who Jazz is hiring next, click here to view […]

Jazz Pharmaceuticals Announces Full Year And Fourth Quarter 2013 Financial Results

[PR Newswire] – DUBLIN, Feb. 25, 2014 /PRNewswire/ — Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced financial results for the full year and the fourth quarter ended December 31, 2013 and provided financial guidance … moreView todays social media effects on JAZZView the latest stocks trending across Twitter. Click to view dashboardSee who Jazz is hiring next, click here to […]

IPO Preview: Concert Pharmaceuticals

moreView todays social media effects on JAZZView the latest stocks trending across Twitter. Click to view dashboardSee who Jazz is hiring next, click here to view […]

Jazz Pharmaceuticals Announces U.S. Commercial Availability Of Versaclozâ„¢ (clozapine, USP) Oral Suspension

[at noodls] – First liquid formulation clozapine for treatment-resistant schizophrenia DUBLIN, Feb. 11, 2014 /PRNewswire/ — Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced U.S. commercial availability of Versaclozâ„¢ … moreView todays social media effects on JAZZView the latest stocks trending across Twitter. Click to view dashboardSee who Jazz is hiring next, click here to view […]